Welcome to Alphapharm
Better Health for a Better World: Mylan acquires Abbott's non-U.S. developed markets specialty and branded generics business
Alphapharm has been researching, developing and making generic medicines in Australia for more than 30 years. Millions of Australians take an Alphapharm generic medicine every day. In fact, we've become the largest supplier of medicines to the subsidised PBS and Australia's leader in generic medicines.
Alphapharm medicines are available Australia-wide. Alphapharm medicines are made to the highest global quality standards and exported to more than 50 countries, including those in Europe and the US.
Globally, we are part of Mylan whose broad offering includes the world's second largest portfolio of active pharmaceutical ingredients (APIs) and a powerful pipeline with more than 200 applications or dossiers pending regulatory approval. The structure of our company enables us to leverage Mylan's global platform while maintaining a very strong emphasis on meeting local market needs and expectations.